Patent intelligence · US
US 11802237
Method for producing powder containing zirconia particles and fluorescent agent
Method for producing powder containing zirconia particles and fluorescent agent
Patent details — US 11802237
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 31, 2023
- Expiration
- Oct 26, 2043
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Claims
- 16
- CPC classes
- A61K, A61K6/818, A61K6/822, A61K6/887
Quick answer
US 11802237 (Method for producing powder containing zirconia particles and fluorescent agent) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Oct 31, 2023. Expires Oct 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K6/818, A61K6/822, A61K6/887
More from KURARAY NORITAKE DENTAL INC.
Related pharmaceutical patents in our USPTO index.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted
Frequently asked questions
What is US patent 11802237?
US 11802237 (Method for producing powder containing zirconia particles and fluorescent agent) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Oct 31, 2023. Expires Oct 26, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11802237?
KURARAY NORITAKE DENTAL INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.
When does US 11802237 expire?
Our index shows an expiration date of Oct 26, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.